We are live on
!
Find out more
OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$9.63B
1-Year Est. Return
30.32%
This Fund
S&P 500
This Quarter
Est. Return
-3.2%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$6.52B
AUM Growth
-$282M
(-4.1%)
Cap. Flow
-$5.08M
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
16.75%
Holding
1,180
New
46
Increased
482
Reduced
596
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$29.8M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$18.3M |
| 3 |
Chevron
CVX
|
+$10.4M |
| 4 |
Citigroup
C
|
+$7.39M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$7.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FedEx
FDX
|
+$31.3M |
| 2 |
Kimberly-Clark
KMB
|
+$9.73M |
| 3 |
Cisco
CSCO
|
+$9.24M |
| 4 |
Cognizant
CTSH
|
+$7.95M |
| 5 |
Philip Morris
PM
|
+$7.91M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.01% |
| 2 | Healthcare | 13.41% |
| 3 | Financials | 13.36% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Highwoods Properties
HIW
$3.41B
| $551K | 0.01% |
26,723
-3,048
| -10% | -$72.4K |
|
827
Global X Genomics & Biotechnology ETF
GNOM
$87.3M
| $550K | 0.01% |
13,529
+1,400
| +12% | +$63.7K |
|
|
DOC
828
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $548K | 0.01% |
44,938
-490
| -1% | -$6.77K |
|
829
Vericel Corp
VCEL
$2.25B
| $546K | 0.01% |
16,286
-148
| -0.9% | -$5.13K |
|
830
Affirm
AFRM
$25.3B
| $543K | 0.01% |
25,533
+839
| +3% | +$15.3K |
|
|
BLD
831
DELISTED
TopBuild
BLD
| $539K | 0.01% |
2,143
-524
| -20% | -$144K |
|
832
A.O. Smith
AOS
$8.48B
| $538K | 0.01% |
8,133
-976
| -11% | -$69.3K |
|
833
Natera
NTRA
$45.9B
| $536K | 0.01% |
12,115
+2,053
| +20% | +$105K |
|
|
WNS
834
DELISTED
WNS Holdings
WNS
| $535K | 0.01% |
7,819
-83
| -1% | -$5.61K |
|
835
iShares Russell 3000 ETF
IWV
$20.4B
| $535K | 0.01% |
2,182
+152
| +7% | +$38.8K |
|
836
iShares S&P 500 Value ETF
IVE
$50B
| $530K | 0.01% |
3,447
+250
| +8% | +$40.4K |
|
837
ARK Autonomous Technology & Robotics ETF
ARKQ
$2.06B
| $528K | 0.01% |
10,073
-226
| -2% | -$12.5K |
|
838
V2X
VVX
$2.6B
| $524K | 0.01% |
10,139
-51
| -0.5% | -$2.56K |
|
839
Champion Homes
SKY
$5.04B
| $523K | 0.01% |
8,202
+4,857
| +145% | +$326K |
|
840
Chemed
CHE
$7.18B
| $522K | 0.01% |
1,004
-8
| -0.8% | -$4.16K |
|
841
iShares Global Industrials ETF
EXI
$1.48B
| $521K | 0.01% |
4,614
+332
| +8% | +$39.5K |
|
842
Owens Corning
OC
$12.2B
| $519K | 0.01% |
3,805
-495
| -12% | -$68K |
|
843
Arrow Electronics
ARW
$10.3B
| $514K | 0.01% |
4,107
+31
| +0.8% | +$4.13K |
|
844
Roku
ROKU
$22.5B
| $513K | 0.01% |
7,266
+115
| +2% | +$8.9K |
|
|
JBTM
845
JBT Marel
JBTM
$6.35B
| $507K | 0.01% |
4,826
+9
| +0.2% | +$1.01K |
|
846
Ecovyst
ECVT
$1.1B
| $503K | 0.01% |
51,153
-9,454
| -16% | -$101K |
|
847
Guardant Health
GH
$22.4B
| $500K | 0.01% |
16,854
+453
| +3% | +$15.9K |
|
848
Ionis Pharmaceuticals
IONS
$9.46B
| $498K | 0.01% |
10,968
-51
| -0.5% | -$2.1K |
|
849
Ascendis Pharma A/S
ASND
$16.8B
| $495K | 0.01% |
5,284
-286
| -5% | -$26.8K |
|
850
Iron Mountain
IRM
$36.2B
| $494K | 0.01% |
8,315
-4,053
| -33% | -$248K |
|
Similar funds
TIM
SC
TCA
CCMT
LAMI
DCP
HL
FCM
Oppenheimer Asset Management's Q3 2023 Portfolio in Review
As of Q3 2023, Oppenheimer Asset Management held 1,180 positions worth $6.52B, down 4.1% from $6.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Oppenheimer Asset Management's Q3 2023 filing shows 46 new, 482 increased, 596 reduced and 54 closed positions. Its largest new stake was Kenvue: 1,289,137 shares worth $25.9M. The largest sale was FedEx, an estimated $31.3M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Oppenheimer Asset Management's largest Q3 2023 buy was Kenvue: 1,289,137 shares worth $25.9M.
- Oppenheimer Asset Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2023, an estimated $18.3M increase.
- Oppenheimer Asset Management's biggest Q3 2023 reduction was FedEx, cutting an estimated $31.3M.
- Oppenheimer Asset Management fully exited Amedisys in Q3 2023, selling an estimated $6.32M.
- Oppenheimer Asset Management's ten largest holdings make up 17% of its $6.52B portfolio in Q3 2023.
- Oppenheimer Asset Management opened 46 new positions and closed 54 in Q3 2023.
- Oppenheimer Asset Management's portfolio value fell 4.1% quarter-over-quarter to $6.52B.
Based on Oppenheimer Asset Management's 13F filing for Q3 2023, filed 8 Nov 2023.